Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Silent brain infarction (SBI) is a hidden comorbidity, mostly unrecognized in CKD patients which increases the risk of symptomatic stroke, dementia and overt neurological mortality. The relationship between SBI and chronic kidney disease (CKD) is unknown. It is supposed that SBI will predict the progression of diseases processes in CKD patients.
This cross-sectional study was carried out in the Department of Nephrology , Dhaka Medical College Hospital, Dhaka, during september 2018 to march, 2020. A total of 115 subjects were enrolled in this study. 85 patients of CKD stage3-5 (non dialytic) who have no neurological symptoms suggesting stroke were considered as group I and the rest 30 were healthy control who were considered as group II. Glomerular filtration rate (GFR) was estimated using Modification of Diet in Renal Diseases equation. All study subjects underwent magnetic resonance imaging (MRI). Statistical analysis of the results were obtained by using window based computer software device with Statistical Packages for Social Sciences (SPSS-22).
The rate of Silent Brain Infarction is 52.9% in CKD patients. SBI was found in 45(52.9%) patients in group I and 4(13.3%) in group II. The differences was statistically significant (p<0.05). Glomerulonephritis (45.9%) was the leading cause of CKD among the study patients. Most of the patients of Hypertensive Nephrosclerosis(76.9%) had SBI indirectly showed its strong association. As the stages of CKD progressed the rate of SBI was also increased (stage-3:8.9%; stage-4:35.6%; stage-5ND:55.6%). In a multivariate logistic regression analysis CKD had independent relationship with SBI along with serum phosphate level and serum parathyroid hormone level (CKD had Odds ratio (OR)=1.847 (95.0% C.I 0.064 to 53.319), serum PO4 had OR=0.958 (95.0% C.I. 0.885 to 1.038) and serum PTH had OR=0.996 (95.0% C.I. 0.993 to 1.000). Spearman rank correlation coefficient test showed positive correlation between the occurrence of SBI and serum PO4 level (r=0.416; p=0.001) and serum PTH level (r= 0.405; p=0.001) separately.
The rate of SBI in CKD (stage 3-5,non dialytic) patients is high which is 52.9% and serum PO4 and serum PTH level have positive correlation with the occurrence of SBI in CKD stage 3-5(non dialytic) patients.
